ITPA deficiency and ribavirin level are still predictive of anaemia in HCV–HIV-coinfected patients receiving ribavirin combined with a first-generation DAA (ANRS HC27 study) - Université de Rennes Accéder directement au contenu
Article Dans Une Revue Antiviral Therapy Année : 2017

ITPA deficiency and ribavirin level are still predictive of anaemia in HCV–HIV-coinfected patients receiving ribavirin combined with a first-generation DAA (ANRS HC27 study)

Fichier non déposé

Dates et versions

hal-01671461 , version 1 (22-12-2017)

Identifiants

Citer

Farid Kheloufi, Isabelle Poizot-Martin, Rodolphe Garraffo, Aude Tavenard, Sylvie Quaranta, et al.. ITPA deficiency and ribavirin level are still predictive of anaemia in HCV–HIV-coinfected patients receiving ribavirin combined with a first-generation DAA (ANRS HC27 study). Antiviral Therapy, 2017, 22 (6), pp.461-469. ⟨10.3851/IMP3074⟩. ⟨hal-01671461⟩
58 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More